Aspen Pharmacare Holdings Limited APN
JSE · South Africa · Health Technology
ZAc 15,945.00+111.00 (+0.70%)
Market open· · ZAc · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · ZAc · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Here is how Aspen Pharmacare (APNHY) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
Here is how Aspen Pharmacare (APNHY) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.
Aspen Pharmacare Holdings Ltd (APNHF) guides to over 50% NHEPS growth in FY27, driven by a raised sterile EBITDA target and a strong net cash position.
Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited ("Aspen"), today announced that Health Canada has approved ᴾʳAspen-Semaglutide, a generic equivalent of Ozempic® (semaglutide injection), for the treatment of adults with type 2 diabetes mellitus to improve glycemic control, in combination with diet and exercise.¹ Aspen-Semaglutide will offer both the 2 mg and 4 mg pen formats.
From what we can see, insiders were net buyers in Aspen Pharmacare Holdings Limited's ( JSE:APN ) during the past 12...
Africa's largest drugmaker plans to sell Asia-Pacific assets excluding China to BGH Capital for 26.5 billion rand.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.